Phytochemical analysis, therapeutic and molecular docking studies for the compounds of wild type and Senkambu variants of curry leaves targeting HER2 Kinase domain a potential gastric cancer receptor
DOI:
https://doi.org/10.14719/pst.4579Keywords:
bio-active compounds, curry leaf, docking, gastric cancer, piperineAbstract
Gastric cancer is the fifth most notable health concern globally. In recent years, molecular docking, a computational technique, has emerged as tool in drug discovery. The present investigation aimed to identify the major bioactive compounds in the wild-type curry leaves found in the Shevaroy Hills and the local Senkambu variant from Karamadai. Virtual screening of 40 ligands from Curry leaves of wild type and Senkambu type was identified through GC-MS profiling. These compounds were targeted against HER2 Kinase domain which is a potential receptor for Gastric cancer. Information regarding the binding site residues for the receptor was predicted using CASTp server. Molecular docking was performed for HER2 kinase domain with the predicted compounds through GC-MS profiling. The top 3 hits reported with least binding affinity for the target protein were considered for further interaction analysis using Biovia Discovery studio visualizer. Upon analyzing the interacted compounds, the Piperine from Wild type curry leaves was found to have good interaction with HER2 Kinase domain by forming two hydrogen bonds and binding score of -8.3 k cal/mol. The current study might guide the designing of analogues of piperine in the evolution of effective broad spectrum drug development in cancer therapy.
Downloads
References
Mamun TI, Younus S, Rahman MH. Gastric Cancer-Epidemiology, Modifiable and Non-modifiable Risk Factors, Challenges and Opportunities: An Updated Review. Cancer Treatment and Research Communications. 2024;24:100845. https://doi.org/10.1016/j.ctarc.2024.100845
Scheck MK, Hofheinz RD, Lorenzen S. HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments. Cancers. 2024;29(7):1336. https://doi.org/10.3390/cancers16071336
Takiuchi H, Ohtsu A, Fuse N, Goto M, Yoshida M, Dote N, Kuze Y, Jinno F, Fujimoto M, Takubo T, Nakayama N. Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients. British journal of cancer. 2012;106(4):666-72. https://doi.org/10.1038/bjc.2011.590
Ho, J. W., Leung, Y., Chan, C. Herbal medicine in the treatment of cancer. Current Medicinal Chemistry-Anti-Cancer Agents. 2002;2(2):209-214. https://doi.org/10.2174/1568011023354164
Sandhya S, Jegadeeswari V, Shoba N, Jeyakumar P. A prelimi-nary study to check the graft compatibility and success percent-age of curry leaf (Murraya koenigii Spreng.). Journal of Pharma-cognosy and Phytochemistry. 2020;9(4):3479-83.
Noolu B, Ismail A. Anti-proliferative and proteasome inhibitory activity of Murraya koenigii leaf extract in human cancer cell lines. Discovery Phytomedicine-Journal of Natural Products Research and Ethnopharmacology. 2015;25(1):1.-9. https://doi.org/10.15562/phytomedicine.2015.18
Balakrishnan R, Vijayraja D, Jo SH, Ganesan P, Su-Kim I, Choi DK. Medicinal profile, phytochemistry, and pharmacological activities of Murraya koenigii and its primary bioactive com-pounds. Antioxidants. 2020;24(2):101. https://doi.org/10.3390 %2Fantiox9020101
Raghu BR. Diversity and Distribution of Curry Leaf in India. Jour-nal of Horticultural Sciences. 2020;15(1):1-8.
Vali DM, Venkatesan K, Senthil N, Selvi BS, Raveendran M. Com-parative analysis of Curcuma species essential oil through gas chromatography-mass spectrometry. Medicinal Plants-International Journal of Phytomedicines and Related Industries. 2022;14(4):632-6.
Santhanakrishnan VP, Shoba N, Varun E, Mohankumar S, Raveendran M. Aromatic profiling of Murraya koenigii leaves by Thermal Desorption Gas chromatography-Mass Spectroscopy (TD-GC-MS). Heliyon. 2023 Jul 1;9(7).
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient opti-mization, and multithreading. Journal of computational chem-istry. 2010;31(2):455-61.
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chem-istry friendliness of small molecules. Scientific reports. 2017;7(1):42717
Shin SA, Lee HN, Choo GS, Kim SJ, Kim HJ, Park YS, Park BK, Kim BS, Kim SK, Lee HJ, Jung JY. Induction of apoptosis and inhibi-tion of growth in human gastric cancer by piperine. Journal of the Korean Society of Food Science and Nutrition. 2016;45(11):1589-94. https://doi.org/10.3746/jkfn.2016.45.11.1589
Zadorozhna M, Tataranni T, Mangieri D. Piperine: role in preven-tion and progression of cancer. Molecular biology reports. 2019;46(5):5617-29.
Turrini E, Sestili P, Fimognari C. Overview of the anticancer po-tential of the “king of spices” Piper nigrum and its main constit-uent piperine. Toxins. 2020;26:(12):747. https://doi.org/10.1186/s43088-022-00196-1
Xia Y, Khoi PN, Yoon HJ, Lian S, Joo YE, Chay KO, Kim KK, Jung YD. Piperine inhibits IL-1?-induced IL-6 expression by suppress-ing p38 MAPK and STAT3 activation in gastric cancer cells. Mo-lecular and cellular biochemistry. 2015;398:147-56.
Chen H, Sheng H, Zhao Y, Zhu G. Piperine inhibits cell prolifera-tion and induces apoptosis of human gastric cancer cells by downregulating phosphatidylinositol 3-kinase (PI3K)/Akt path-way. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2020;26:e928403-1.
Tripathi AK, Ray AK, Mishra SK. Molecular and pharmacological aspects of piperine as a potential molecule for disease preven-tion and management: evidence from clinical trials. Beni-Suef university journal of basic and applied sciences. 2022;28(1):16. https://doi.org/10.1186/s43088-022-00196-1
Binlong, Chen., Yanzhong, Zhao., Zichang, Lin., Jiahao, Liang., Jialong, Fan., Yanyan, Huang., Leye, He., Bin, Liu. 2. Apatinib and gamabufotalin co-loaded lipid/prussian blue nanoparticles forsynergistic therapy to gastric cancer with metastasis. Journal of Pharmaceutical Analysis, (2023). https://doi.org/10.1016/j.jpha.2023.11.011
Ramos IN, da Silva MF, Lopes JM, Cruz JN, Alves FS, do Rego JD, Costa ML, Assumpção PP, Barros Brasil DD, Khayat AS. Extrac-tion, characterization, and evaluation of the cytotoxic activity of piperine in its isolated form and in combination with chemo-therapeutics against gastric cancer. Molecules. 2023;28(14):5587. https://doi.org/10.3390/molecules28145587
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 S sandhya, V Jegadeeswari , M Jayakanthan , R Caroline Nirmala
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright and Licence details of published articles
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Open Access Policy
Plant Science Today is an open access journal. There is no registration required to read any article. All published articles are distributed under the terms of the Creative Commons Attribution License (CC Attribution 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited (https://creativecommons.org/licenses/by/4.0/). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).